Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00178-20Source: DataRank Database

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 84 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access84 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (40)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Sondus Alkhazraji,Abdullah Alqarihi ORCID,Nathan P. Wiederhold ORCID,Karen Joy Shaw ORCID,Thomas F. Patterson ORCID

Live enrichment

PubMed:32205345 PMC:PMC7269494

Amplyx

Grant: 21922-03

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: HHSN272201100038I

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: HHSNHHSN272201100018I

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI063503

NIAID NIH HHS

Grant: HHSN272201000038I

NIAID NIH HHS

Grant: HHSN272201100038C

National Institutes of Health

Grant: 5R01AI063503-12

Novel Toxins and Receptors in Mucormycosis Pathogenesis

hybridLicense: CC BY

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.00178-20

Unpaywallhttps://escholarship.org/uc/item/73g6f33c

Europe_PMChttps://europepmc.org/articles/PMC7269494

Europe_PMChttps://europepmc.org/articles/PMC7269494?pdf=render

https://doi.org/10.1128/aac.00178-20

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsHumansMiceRhizopusMucormycosisIsoxazolesAntifungal AgentsMicrobial Sensitivity TestsRhizopus oryzae

Keywords

Infectious diseaseRhizopus arrhizusAntifungal agentsantifungalMucormycosisInfection Model1-AminobenzotriazoleMgxGwt1ManogepixFosmanogepixApx001aApx001Microbial Sensitivity TestsMicrobiologyMiceAnimalsHumansExperimental TherapeuticsLungPharmacology and Pharmaceutical SciencesIsoxazolesInfectious DiseasesEmerging Infectious DiseasesMedical MicrobiologyRhizopus oryzaeInfectionRhizopus

Sustainable Development Goals

SDG 3: 3. Good health